PulseSight Competitors and Similar CompaniesClear all

PulseSight's competitors and similar companies include OrthoPediatrics, Cardiac Dimensions, Emulate and Genotypic Technology.

	PulseSight PulseSight Therapeutics (formerly known as Eyevensys) is a biotechnology company that develops an EyeCET platform to enable the sustained intraocular production of therapeutic proteins to treat ophthalmic diseases.	OrthoPediatrics OrthoPediatrics designs, develops, manufactures, and distributes orthopedic implants and instruments for pediatric orthopedic surgeons.	Cardiac Dimensions Cardiac Dimensions is a medical device company developing tools and techniques for the treatment of heart failure and related conditions.	Emulate Emulate is a biotechnology company that specializes in organ-on-chips technology.	Genotypic Technology Genotypic Technology is a company that provides genomics, microarray, bioinformatics and next-generation sequencing (NGS) solutions and services.
Founding Date	Founding Date 2008	Founding Date 2006	Founding Date 2000	Founding Date 2014	Founding Date 1998
Type	Type Private	Type Public	Type Private	Type Private	Type Private
Tags	Tags Healthcare biotech healthtech medical devices	Tags Healthcare biotech healthtech medical devices	Tags Healthcare biotech healthtech medical devices	Tags Healthcare biotech healthtech medical devices	Tags Healthcare biotech healthtech medical devices
Locations	Locations Paris, FR HQ Paris, FR Cambridge, US	Locations Warsaw, US HQ	Locations Kirkland, US HQ Macquarie Park, AU Offenbach Am Main, DE	Locations Boston, US HQ	Locations Bengaluru, IN HQ
Employees	Employees 9	Employees 9418% increase	Employees 653% increase	Employees 802% decrease	Employees 1146% increase
Funding
Latest funding round	Latest funding round $ 30m (over 6 years ago)	Latest funding round N/A	Latest funding round $ 17.5m (over 5 years ago)	Latest funding round $ 36m (almost 8 years ago)	Latest funding round N/A
Total funding raised	Total funding raised $ 40.1m	Total funding raised $ 39m	Total funding raised $ 178.5m	Total funding raised $ 95m	Total funding raised N/A